<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01260350</url>
  </required_header>
  <id_info>
    <org_study_id>P7977-0523</org_study_id>
    <secondary_id>Medsafe</secondary_id>
    <nct_id>NCT01260350</nct_id>
  </id_info>
  <brief_title>Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3</brief_title>
  <official_title>A Multi-center, Open-Labeled Exploratory Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Oral Administration of PSI-7977 400 mg and Ribavirin for 12 Weeks With and Without Pegylated Interferon in Treatment-Naïve Patients With Chronic HCV Infection Genotype 2 or Genotype 3</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gilead Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to assess the safety and tolerability of sofosbuvir (SOF) 400 mg with and
      without ribavirin (RBV) and/or with and without pegylated interferon alfa-2a (PEG) in
      subjects with genotype 1, 2 or 3 hepatitis C (HCV) infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Part 1: HCV genotype 2 or 3: participants will receive SOF 400 mg once daily with
      weight-based RBV for 12 weeks. Participants will be randomized in equal proportions to: no
      PEG (Arm 1), PEG for 4 weeks (Arm 2), PEG for 8 weeks (Arm 3), or PEG for 12 weeks (Arm 4).

      Part 2: HCV genotype 2 or 3: participants will receive SOF 400 mg once daily (monotherapy)
      for 12 weeks (Arm 5), or SOF 400 mg once daily with PEG and weight-based RBV for 8 weeks (Arm
      6); HCV genotype 1: null responders (did not respond to their prior treatment) will receive
      SOF 400 mg once daily with weight-based RBV for 12 weeks (Arm 7).

      Part 3: HCV genotype 1 treatment-naive (Arm 8) or HCV genotype 2 or 3 treatment-experienced
      participants (Arm 9) will receive SOF 400 mg once daily in combination with weight-based RBV
      for 12 weeks.

      Part 4: HCV genotype 2 or 3 treatment naive participants will receive SOF 400 mg once daily
      with weight-based RBV for 8 weeks (Arm 10) or SOF 400 mg once daily and 800 mg RBV for 12
      weeks (Arm 11). HCV genotype 1 null responders will receive SOF 400 mg once daily, ledipasvir
      (LDV), and weight based RBV for 12 weeks (Arm 12). HCV genotype-1 treatment naive
      participants will receive SOF 400 mg once daily with weight-based RBV and LDV for 12 weeks
      (Arm 13).

      Part 5: HCV genotype 1 null responders will receive SOF 400 mg once daily with GS-9669 500 mg
      once daily and weight-based RBV for 12 weeks (Arm 14). HCV genotype-1 treatment naive
      participants receive SOF 400 mg once daily with GS-9669 500 mg once daily and weight-based
      RBV for 12 weeks (Arm 15).

      Part 6: HCV genotype 1 null responders with Stage F4 fibrosis will receive LDV/SOF FDC for 12
      weeks (Arm 16) or LDV/SOF FDC with weight-based RBV for 12 weeks (Arm 17). HCV genotype 2 or
      3 treatment-naive participants will receive LDV/SOF FDC for 12 weeks (Arm 18). HCV genotype 2
      or 3 treatment-experienced participants will receive LDV/SOF FDC for 12 weeks (Arm 19). HCV
      genotype 1 hemophiliacs will receive LDV/SOF FDC with weight-based RBV for 12 weeks (Arm 20).
      HCV genotype 1 treatment-naive participants will receive LDV/SOF FDC with weight-based RBV
      for 6 weeks (Arm 21). HCV genotype 1 treatment-naive participants will receive LDV/SOF FDC
      for 6 weeks (Arm 22).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Who Experienced Adverse Events</measure>
    <time_frame>Up to 12 weeks plus 30 days</time_frame>
    <description>Adverse events (AEs) occurring from baseline (Day 1 for all groups) to 30 days following the last dose of study drug were summarized across the participant population. A participant was counted once if they had a qualifying event.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Sustained Virologic Response 12 Weeks Following Completion of Treatment (SVR12)</measure>
    <time_frame>Posttreatment Week 12</time_frame>
    <description>SVR12 was defined as HCV RNA &lt; the limit of detection (LOD; &lt; 15 IU/mL) 12 weeks after the last dose of study drug.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With HCV RNA &lt; LOD at Week 6</measure>
    <time_frame>Week 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With HCV RNA &lt; LOD at Week 8</measure>
    <time_frame>Week 8</time_frame>
    <description>Data are not presented for Group 21 which ended treatment after Week 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With HCV RNA &lt; LOD at Week 12</measure>
    <time_frame>Week 12</time_frame>
    <description>Data are not presented for Groups 6, 10, and 21 which ended treatment after Week 8 or Week 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HCV RNA at Week 6</measure>
    <time_frame>Baseline to Week 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HCV RNA at Week 8</measure>
    <time_frame>Baseline to Week 8</time_frame>
    <description>Data are not presented for Group 21 which ended treatment after Week 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HCV RNA at Week 12</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>Data are not presented for Groups 6, 10, and 21 which ended treatment after Week 8 or Week 6. Data are not presented for Groups 16, 17, 18, and 20 because participants with detectable HCV RNA discontinued due to protocol-specified stopping rules.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Virologic Failure</measure>
    <time_frame>Up to Posttreatment Week 24</time_frame>
    <description>The percentage of participants with on-treatment virologic failure (viral breakthrough, rebound, or nonresponse) or following treatment (viral relapse) was summarized.
On-treatment virologic failure was defined as:
Viral breakthrough (confirmed HCV RNA ≥ LOD after having previously had HCV RNA &lt; LOD while on treatment),
Viral rebound (confirmed &gt; 1 log10 IU/mL increase in HCV RNA from nadir while on treatment, or
Nonresponse (HCV RNA persistently ≥ LOD through 6 weeks of treatment)
Viral relapse was defined as confirmed HCV RNA ≥ LOD during the posttreatment period having achieved HCV RNA &lt; LOD at the last on-treatment visit.</description>
  </secondary_outcome>
  <number_of_arms>22</number_of_arms>
  <enrollment type="Actual">292</enrollment>
  <condition>Chronic Hepatitis C Infection</condition>
  <arm_group>
    <arm_group_label>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: SOF+RBV 12 wk+PEG 4 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily+weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5: SOF 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 7: SOF+RBV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 8: SOF+RBV 12 wk: GT 1, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 1 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 1 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 1 HCV infection will receive SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 16: LDV/SOF FDC 12 wk: GT 1, fibrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced participants with genotype 1 HCV infection and Stage F4 fibrosis who did not respond to prior treatment will receive LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, fibrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment will receive LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 2 or 3 HCV infection will receive LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 19: LDV/SOF FDC 12 wk: GT 2 or 3, TE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-experienced participants with genotype 2 or 3 HCV infection will receive LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, hemophiliac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemophiliac participants with genotype 1 HCV infection will receive LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 1 HCV infection will receive LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 22: LDV/SOF FDC 6 wk: GT 1, TN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment-naive participants with genotype 1 HCV infection were randomized to receive LDV 90 mg/SOF 400 mg FDC once daily for 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SOF</intervention_name>
    <description>Sofosbuvir (SOF) tablets administered orally once daily</description>
    <arm_group_label>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 2: SOF+RBV 12 wk+PEG 4 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 5: SOF 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 7: SOF+RBV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 8: SOF+RBV 12 wk: GT 1, TN</arm_group_label>
    <arm_group_label>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</arm_group_label>
    <arm_group_label>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</arm_group_label>
    <arm_group_label>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</arm_group_label>
    <other_name>Sovaldi®</other_name>
    <other_name>GS-7977</other_name>
    <other_name>PSI-7977</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RBV</intervention_name>
    <description>Ribavirin (RBV) capsules administered orally in a divided daily dose</description>
    <arm_group_label>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 2: SOF+RBV 12 wk+PEG 4 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 7: SOF+RBV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 8: SOF+RBV 12 wk: GT 1, TN</arm_group_label>
    <arm_group_label>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</arm_group_label>
    <arm_group_label>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</arm_group_label>
    <arm_group_label>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</arm_group_label>
    <arm_group_label>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, fibrosis</arm_group_label>
    <arm_group_label>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, hemophiliac</arm_group_label>
    <arm_group_label>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</arm_group_label>
    <other_name>Copegus®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG</intervention_name>
    <description>Peginterferon alfa-2a (PEG) administered via subcutaneous injection once weekly</description>
    <arm_group_label>Group 2: SOF+RBV 12 wk+PEG 4 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</arm_group_label>
    <other_name>Pegasys®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LDV</intervention_name>
    <description>Ledipasvir (LDV) tablets administered orally once daily</description>
    <arm_group_label>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</arm_group_label>
    <other_name>GS-5885</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GS-9669</intervention_name>
    <description>GS-9669 tablets administered orally once daily</description>
    <arm_group_label>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</arm_group_label>
    <arm_group_label>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LDV/SOF</intervention_name>
    <description>LDV/SOF fixed-dose combination (FDC) tablet administered once daily</description>
    <arm_group_label>Group 16: LDV/SOF FDC 12 wk: GT 1, fibrosis</arm_group_label>
    <arm_group_label>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, fibrosis</arm_group_label>
    <arm_group_label>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</arm_group_label>
    <arm_group_label>Group 19: LDV/SOF FDC 12 wk: GT 2 or 3, TE</arm_group_label>
    <arm_group_label>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, hemophiliac</arm_group_label>
    <arm_group_label>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</arm_group_label>
    <arm_group_label>Group 22: LDV/SOF FDC 6 wk: GT 1, TN</arm_group_label>
    <other_name>Harvoni®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Genotype 2 or 3 HCV-infection or Genotype 1, serum HCV RNA ≥ 50,000 IU/mL

          -  Not co-infected with HIV

          -  Use of highly effective contraception methods if female of childbearing potential or
             sexually active male

        Exclusion Criteria:

          -  History of any other clinically significant chronic liver disease

          -  Pregnant or nursing female or male with pregnant female partner

          -  History of significant drug allergy to nucleoside/nucleotide analogs.

          -  Participation in a clinical study within 3 months prior to first dose

          -  Positive result for significant drug use at Screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert H. Hyland, DPhil</last_name>
    <role>Study Director</role>
    <affiliation>Gilead Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Auckland Clinical Studies Ltd.</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Clinical Studies Trust</name>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <results_reference>
    <citation>Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Subramanian GM, Symonds WT, McHutchison JG, Pang PS. Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection. Gastroenterology. 2014 Mar;146(3):736-743.e1. doi: 10.1053/j.gastro.2013.11.007. Epub 2013 Nov 18.</citation>
    <PMID>24262278</PMID>
  </results_reference>
  <results_reference>
    <citation>Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, Hindes RG, Berrey MM. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med. 2013 Jan 3;368(1):34-44. doi: 10.1056/NEJMoa1208953.</citation>
    <PMID>23281974</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2010</study_first_submitted>
  <study_first_submitted_qc>December 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2010</study_first_posted>
  <results_first_submitted>November 7, 2014</results_first_submitted>
  <results_first_submitted_qc>November 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 17, 2014</results_first_posted>
  <disposition_first_submitted>May 28, 2014</disposition_first_submitted>
  <disposition_first_submitted_qc>May 28, 2014</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">June 2, 2014</disposition_first_posted>
  <last_update_submitted>November 7, 2014</last_update_submitted>
  <last_update_submitted_qc>November 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PSI-7977</keyword>
  <keyword>Sofosbuvir</keyword>
  <keyword>GS-7977</keyword>
  <keyword>GS-5885</keyword>
  <keyword>GS-9669</keyword>
  <keyword>FDC</keyword>
  <keyword>ribavirin</keyword>
  <keyword>RBV</keyword>
  <keyword>Pegylated Interferon</keyword>
  <keyword>PEG-IFN</keyword>
  <keyword>Chronic Hepatitis C Infection</keyword>
  <keyword>HCV</keyword>
  <keyword>Hepatitis</keyword>
  <keyword>Genotype 1</keyword>
  <keyword>Genotype 2</keyword>
  <keyword>Genotype 3</keyword>
  <keyword>GT 1</keyword>
  <keyword>GT 2</keyword>
  <keyword>GT 3</keyword>
  <keyword>Hemophilia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Ribavirin</mesh_term>
    <mesh_term>Sofosbuvir</mesh_term>
    <mesh_term>Ledipasvir</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled in a total of 2 study sites in New Zealand. The first participant was screened on 18 November 2010. The last participant observation was on 23 December 2013.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
          <description>Sofosbuvir (SOF) 400 mg once daily plus weight-based ribavirin (RBV) (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
        </group>
        <group group_id="P2">
          <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P3">
          <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P4">
          <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P5">
          <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P6">
          <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P7">
          <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="P8">
          <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="P9">
          <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P10">
          <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P11">
          <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P12">
          <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus ledipasvir (LDV) 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="P13">
          <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="P14">
          <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="P15">
          <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="P16">
          <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
          <description>LDV 90 mg/SOF 400 mg fixed-dose combination (FDC) once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
        </group>
        <group group_id="P17">
          <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
        </group>
        <group group_id="P18">
          <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P19">
          <title>Group 19: LDV/SOF FDC 12 wk: GT 2 or 3, TE</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="P20">
          <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="P21">
          <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="P22">
          <title>Group 22: LDV/SOF FDC 6 wk: GT 1, TN</title>
          <description>Treatment-naive participants with genotype 1 HCV infection were randomized to receive LDV 90 mg/SOF 400 mg FDC once daily for 6 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="10"/>
                <participants group_id="P7" count="10"/>
                <participants group_id="P8" count="25"/>
                <participants group_id="P9" count="25"/>
                <participants group_id="P10" count="25"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="9"/>
                <participants group_id="P13" count="25"/>
                <participants group_id="P14" count="10"/>
                <participants group_id="P15" count="25"/>
                <participants group_id="P16" count="10"/>
                <participants group_id="P17" count="9"/>
                <participants group_id="P18" count="10"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="14"/>
                <participants group_id="P21" count="25"/>
                <participants group_id="P22" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="10"/>
                <participants group_id="P7" count="10"/>
                <participants group_id="P8" count="25"/>
                <participants group_id="P9" count="24"/>
                <participants group_id="P10" count="25"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="9"/>
                <participants group_id="P13" count="25"/>
                <participants group_id="P14" count="10"/>
                <participants group_id="P15" count="25"/>
                <participants group_id="P16" count="10"/>
                <participants group_id="P17" count="9"/>
                <participants group_id="P18" count="9"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="14"/>
                <participants group_id="P21" count="22"/>
                <participants group_id="P22" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="3"/>
                <participants group_id="P22" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="3"/>
                <participants group_id="P22" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did Not Complete Follow-up 12 Visit</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Safety Analysis Set: participants were randomized and received at least one dose of study medication.</population>
      <group_list>
        <group group_id="B1">
          <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
        </group>
        <group group_id="B2">
          <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B3">
          <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B4">
          <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B5">
          <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B6">
          <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B7">
          <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="B8">
          <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="B9">
          <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B10">
          <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B11">
          <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B12">
          <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="B13">
          <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="B14">
          <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="B15">
          <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="B16">
          <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
        </group>
        <group group_id="B17">
          <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
        </group>
        <group group_id="B18">
          <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="B19">
          <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="B20">
          <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="B21">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="11"/>
            <count group_id="B5" value="10"/>
            <count group_id="B6" value="10"/>
            <count group_id="B7" value="10"/>
            <count group_id="B8" value="25"/>
            <count group_id="B9" value="25"/>
            <count group_id="B10" value="25"/>
            <count group_id="B11" value="10"/>
            <count group_id="B12" value="9"/>
            <count group_id="B13" value="25"/>
            <count group_id="B14" value="10"/>
            <count group_id="B15" value="25"/>
            <count group_id="B16" value="10"/>
            <count group_id="B17" value="9"/>
            <count group_id="B18" value="10"/>
            <count group_id="B19" value="14"/>
            <count group_id="B20" value="25"/>
            <count group_id="B21" value="292"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47" spread="6.0"/>
                    <measurement group_id="B2" value="47" spread="10.2"/>
                    <measurement group_id="B3" value="49" spread="9.9"/>
                    <measurement group_id="B4" value="46" spread="6.3"/>
                    <measurement group_id="B5" value="43" spread="13.5"/>
                    <measurement group_id="B6" value="39" spread="12.2"/>
                    <measurement group_id="B7" value="48" spread="10.4"/>
                    <measurement group_id="B8" value="48" spread="11.4"/>
                    <measurement group_id="B9" value="53" spread="7.9"/>
                    <measurement group_id="B10" value="48" spread="9.4"/>
                    <measurement group_id="B11" value="39" spread="8.9"/>
                    <measurement group_id="B12" value="50" spread="13.0"/>
                    <measurement group_id="B13" value="45" spread="9.2"/>
                    <measurement group_id="B14" value="55" spread="6.0"/>
                    <measurement group_id="B15" value="46" spread="9.3"/>
                    <measurement group_id="B16" value="61" spread="4.9"/>
                    <measurement group_id="B17" value="57" spread="5.2"/>
                    <measurement group_id="B18" value="39" spread="10.8"/>
                    <measurement group_id="B19" value="54" spread="13.0"/>
                    <measurement group_id="B20" value="51" spread="9.0"/>
                    <measurement group_id="B21" value="48" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="6"/>
                    <measurement group_id="B10" value="8"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="17"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="12"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="7"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="12"/>
                    <measurement group_id="B21" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="7"/>
                    <measurement group_id="B8" value="15"/>
                    <measurement group_id="B9" value="19"/>
                    <measurement group_id="B10" value="17"/>
                    <measurement group_id="B11" value="7"/>
                    <measurement group_id="B12" value="7"/>
                    <measurement group_id="B13" value="8"/>
                    <measurement group_id="B14" value="7"/>
                    <measurement group_id="B15" value="13"/>
                    <measurement group_id="B16" value="10"/>
                    <measurement group_id="B17" value="8"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="12"/>
                    <measurement group_id="B20" value="13"/>
                    <measurement group_id="B21" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="10"/>
                    <measurement group_id="B8" value="25"/>
                    <measurement group_id="B9" value="25"/>
                    <measurement group_id="B10" value="25"/>
                    <measurement group_id="B11" value="10"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="25"/>
                    <measurement group_id="B14" value="10"/>
                    <measurement group_id="B15" value="25"/>
                    <measurement group_id="B16" value="8"/>
                    <measurement group_id="B17" value="9"/>
                    <measurement group_id="B18" value="10"/>
                    <measurement group_id="B19" value="14"/>
                    <measurement group_id="B20" value="25"/>
                    <measurement group_id="B21" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="20"/>
                    <measurement group_id="B9" value="17"/>
                    <measurement group_id="B10" value="20"/>
                    <measurement group_id="B11" value="9"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="23"/>
                    <measurement group_id="B14" value="9"/>
                    <measurement group_id="B15" value="20"/>
                    <measurement group_id="B16" value="8"/>
                    <measurement group_id="B17" value="9"/>
                    <measurement group_id="B18" value="7"/>
                    <measurement group_id="B19" value="12"/>
                    <measurement group_id="B20" value="22"/>
                    <measurement group_id="B21" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian of Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="6"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="4"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="2"/>
                    <measurement group_id="B21" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hepatitis C Virus (HCV) RNA</title>
          <units>log10 IU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.7" spread="0.42"/>
                    <measurement group_id="B2" value="6.6" spread="0.52"/>
                    <measurement group_id="B3" value="6.4" spread="0.57"/>
                    <measurement group_id="B4" value="6.3" spread="0.76"/>
                    <measurement group_id="B5" value="5.7" spread="0.89"/>
                    <measurement group_id="B6" value="6.1" spread="0.88"/>
                    <measurement group_id="B7" value="6.8" spread="0.55"/>
                    <measurement group_id="B8" value="6.1" spread="0.75"/>
                    <measurement group_id="B9" value="6.5" spread="0.66"/>
                    <measurement group_id="B10" value="6.1" spread="0.80"/>
                    <measurement group_id="B11" value="6.2" spread="0.96"/>
                    <measurement group_id="B12" value="6.9" spread="0.20"/>
                    <measurement group_id="B13" value="5.9" spread="0.85"/>
                    <measurement group_id="B14" value="7.0" spread="0.38"/>
                    <measurement group_id="B15" value="6.3" spread="0.54"/>
                    <measurement group_id="B16" value="6.5" spread="0.57"/>
                    <measurement group_id="B17" value="6.3" spread="0.78"/>
                    <measurement group_id="B18" value="6.1" spread="0.94"/>
                    <measurement group_id="B19" value="6.5" spread="0.51"/>
                    <measurement group_id="B20" value="6.5" spread="0.56"/>
                    <measurement group_id="B21" value="6.3" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HCV RNA Category</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 6 log10 IU/mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="10"/>
                    <measurement group_id="B9" value="5"/>
                    <measurement group_id="B10" value="12"/>
                    <measurement group_id="B11" value="4"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="11"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="8"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="3"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="6"/>
                    <measurement group_id="B21" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥ 6 log10 IU/mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="15"/>
                    <measurement group_id="B9" value="20"/>
                    <measurement group_id="B10" value="13"/>
                    <measurement group_id="B11" value="6"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="14"/>
                    <measurement group_id="B14" value="10"/>
                    <measurement group_id="B15" value="17"/>
                    <measurement group_id="B16" value="8"/>
                    <measurement group_id="B17" value="6"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="12"/>
                    <measurement group_id="B20" value="19"/>
                    <measurement group_id="B21" value="205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HCV Genotype</title>
          <description>There are variations of HCV which are all similar enough to be called HCV, but are distinct enough to be referred to as HCV genotypes.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Genotype 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="10"/>
                    <measurement group_id="B8" value="25"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="25"/>
                    <measurement group_id="B14" value="10"/>
                    <measurement group_id="B15" value="25"/>
                    <measurement group_id="B16" value="10"/>
                    <measurement group_id="B17" value="9"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="14"/>
                    <measurement group_id="B20" value="25"/>
                    <measurement group_id="B21" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="6"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Genotype 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="19"/>
                    <measurement group_id="B10" value="20"/>
                    <measurement group_id="B11" value="10"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="8"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>IL28b Genotype</title>
          <description>CC, CT, and TT alleles are different forms of the IL28b gene.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>CC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="10"/>
                    <measurement group_id="B8" value="25"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="13"/>
                    <measurement group_id="B11" value="4"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="9"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="7"/>
                    <measurement group_id="B16" value="4"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="4"/>
                    <measurement group_id="B20" value="5"/>
                    <measurement group_id="B21" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="6"/>
                    <measurement group_id="B10" value="12"/>
                    <measurement group_id="B11" value="5"/>
                    <measurement group_id="B12" value="7"/>
                    <measurement group_id="B13" value="14"/>
                    <measurement group_id="B14" value="8"/>
                    <measurement group_id="B15" value="14"/>
                    <measurement group_id="B16" value="4"/>
                    <measurement group_id="B17" value="5"/>
                    <measurement group_id="B18" value="6"/>
                    <measurement group_id="B19" value="7"/>
                    <measurement group_id="B20" value="15"/>
                    <measurement group_id="B21" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="19"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="4"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="5"/>
                    <measurement group_id="B21" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cirrhosis Status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="10"/>
                    <measurement group_id="B17" value="9"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="10"/>
                    <measurement group_id="B8" value="25"/>
                    <measurement group_id="B9" value="25"/>
                    <measurement group_id="B10" value="25"/>
                    <measurement group_id="B11" value="10"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="25"/>
                    <measurement group_id="B14" value="10"/>
                    <measurement group_id="B15" value="25"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="10"/>
                    <measurement group_id="B19" value="13"/>
                    <measurement group_id="B20" value="25"/>
                    <measurement group_id="B21" value="272"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Who Experienced Adverse Events</title>
        <description>Adverse events (AEs) occurring from baseline (Day 1 for all groups) to 30 days following the last dose of study drug were summarized across the participant population. A participant was counted once if they had a qualifying event.</description>
        <time_frame>Up to 12 weeks plus 30 days</time_frame>
        <population>Safety Analysis Set: participants were randomized and received at least one dose of study medication.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O20">
            <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Experienced Adverse Events</title>
          <description>Adverse events (AEs) occurring from baseline (Day 1 for all groups) to 30 days following the last dose of study drug were summarized across the participant population. A participant was counted once if they had a qualifying event.</description>
          <population>Safety Analysis Set: participants were randomized and received at least one dose of study medication.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
                <count group_id="O20" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="25"/>
                    <measurement group_id="O9" value="24"/>
                    <measurement group_id="O10" value="25"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="9"/>
                    <measurement group_id="O13" value="24"/>
                    <measurement group_id="O14" value="10"/>
                    <measurement group_id="O15" value="25"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="7"/>
                    <measurement group_id="O19" value="13"/>
                    <measurement group_id="O20" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug-related AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="25"/>
                    <measurement group_id="O9" value="20"/>
                    <measurement group_id="O10" value="21"/>
                    <measurement group_id="O11" value="7"/>
                    <measurement group_id="O12" value="9"/>
                    <measurement group_id="O13" value="24"/>
                    <measurement group_id="O14" value="10"/>
                    <measurement group_id="O15" value="21"/>
                    <measurement group_id="O16" value="5"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="6"/>
                    <measurement group_id="O19" value="12"/>
                    <measurement group_id="O20" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3 or higher AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AE leading to drug discontinuation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="3"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Sustained Virologic Response 12 Weeks Following Completion of Treatment (SVR12)</title>
        <description>SVR12 was defined as HCV RNA &lt; the limit of detection (LOD; &lt; 15 IU/mL) 12 weeks after the last dose of study drug.</description>
        <time_frame>Posttreatment Week 12</time_frame>
        <population>Safety Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O20">
            <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Sustained Virologic Response 12 Weeks Following Completion of Treatment (SVR12)</title>
          <description>SVR12 was defined as HCV RNA &lt; the limit of detection (LOD; &lt; 15 IU/mL) 12 weeks after the last dose of study drug.</description>
          <population>Safety Analysis Set</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
                <count group_id="O20" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="71.5" upper_limit="100.0"/>
                    <measurement group_id="O5" value="60.0" lower_limit="26.2" upper_limit="87.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O7" value="10.0" lower_limit="0.3" upper_limit="44.5"/>
                    <measurement group_id="O8" value="84.0" lower_limit="63.9" upper_limit="9"/>
                    <measurement group_id="O9" value="68.0"/>
                    <measurement group_id="O10" value="64.0" lower_limit="42.5" upper_limit="82.0"/>
                    <measurement group_id="O11" value="60.0" lower_limit="26.2" upper_limit="87.8"/>
                    <measurement group_id="O12" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O13" value="100.0" lower_limit="86.3" upper_limit="100.0"/>
                    <measurement group_id="O14" value="100.0" lower_limit="69.2" upper_limit="100.0"/>
                    <measurement group_id="O15" value="92.0" lower_limit="74.0" upper_limit="99.0"/>
                    <measurement group_id="O16" value="70.0"/>
                    <measurement group_id="O17" value="100.0"/>
                    <measurement group_id="O18" value="80.0"/>
                    <measurement group_id="O19" value="100.0"/>
                    <measurement group_id="O20" value="68.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With HCV RNA &lt; LOD at Week 6</title>
        <time_frame>Week 6</time_frame>
        <population>Safety Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O20">
            <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With HCV RNA &lt; LOD at Week 6</title>
          <population>Safety Analysis Set</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
                <count group_id="O20" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0"/>
                    <measurement group_id="O2" value="100.0"/>
                    <measurement group_id="O3" value="100.0"/>
                    <measurement group_id="O4" value="100.0"/>
                    <measurement group_id="O5" value="100.0"/>
                    <measurement group_id="O6" value="100.0"/>
                    <measurement group_id="O7" value="100.0"/>
                    <measurement group_id="O8" value="100.0"/>
                    <measurement group_id="O9" value="100.0"/>
                    <measurement group_id="O10" value="100.0"/>
                    <measurement group_id="O11" value="100.0"/>
                    <measurement group_id="O12" value="100.0"/>
                    <measurement group_id="O13" value="100.0"/>
                    <measurement group_id="O14" value="100.0"/>
                    <measurement group_id="O15" value="100.0"/>
                    <measurement group_id="O16" value="100.0"/>
                    <measurement group_id="O17" value="100.0"/>
                    <measurement group_id="O18" value="100.0"/>
                    <measurement group_id="O19" value="100.0"/>
                    <measurement group_id="O20" value="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With HCV RNA &lt; LOD at Week 8</title>
        <description>Data are not presented for Group 21 which ended treatment after Week 6.</description>
        <time_frame>Week 8</time_frame>
        <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With HCV RNA &lt; LOD at Week 8</title>
          <description>Data are not presented for Group 21 which ended treatment after Week 6.</description>
          <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0"/>
                    <measurement group_id="O2" value="100.0"/>
                    <measurement group_id="O3" value="100.0"/>
                    <measurement group_id="O4" value="100.0"/>
                    <measurement group_id="O5" value="100.0"/>
                    <measurement group_id="O6" value="100.0"/>
                    <measurement group_id="O7" value="100.0"/>
                    <measurement group_id="O8" value="100.0"/>
                    <measurement group_id="O9" value="100.0"/>
                    <measurement group_id="O10" value="100.0"/>
                    <measurement group_id="O11" value="100.0"/>
                    <measurement group_id="O12" value="100.0"/>
                    <measurement group_id="O13" value="100.0"/>
                    <measurement group_id="O14" value="100.0"/>
                    <measurement group_id="O15" value="100.0"/>
                    <measurement group_id="O16" value="100.0"/>
                    <measurement group_id="O17" value="100.0"/>
                    <measurement group_id="O18" value="100.0"/>
                    <measurement group_id="O19" value="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With HCV RNA &lt; LOD at Week 12</title>
        <description>Data are not presented for Groups 6, 10, and 21 which ended treatment after Week 8 or Week 6.</description>
        <time_frame>Week 12</time_frame>
        <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O7">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O8">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O11">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O16">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O17">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With HCV RNA &lt; LOD at Week 12</title>
          <description>Data are not presented for Groups 6, 10, and 21 which ended treatment after Week 8 or Week 6.</description>
          <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="25"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="10"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="10"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="9"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0"/>
                    <measurement group_id="O2" value="100.0"/>
                    <measurement group_id="O3" value="100.0"/>
                    <measurement group_id="O4" value="100.0"/>
                    <measurement group_id="O5" value="100.0"/>
                    <measurement group_id="O6" value="100.0"/>
                    <measurement group_id="O7" value="100.0"/>
                    <measurement group_id="O8" value="100.0"/>
                    <measurement group_id="O9" value="100.0"/>
                    <measurement group_id="O10" value="100.0"/>
                    <measurement group_id="O11" value="100.0"/>
                    <measurement group_id="O12" value="100.0"/>
                    <measurement group_id="O13" value="100.0"/>
                    <measurement group_id="O14" value="100.0"/>
                    <measurement group_id="O15" value="100.0"/>
                    <measurement group_id="O16" value="100.0"/>
                    <measurement group_id="O17" value="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HCV RNA at Week 6</title>
        <time_frame>Baseline to Week 6</time_frame>
        <population>Safety Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O20">
            <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HCV RNA at Week 6</title>
          <population>Safety Analysis Set</population>
          <units>log10 IU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
                <count group_id="O20" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.52" spread="0.418"/>
                    <measurement group_id="O2" value="-5.44" spread="0.519"/>
                    <measurement group_id="O3" value="-5.23" spread="0.571"/>
                    <measurement group_id="O4" value="-5.20" spread="0.756"/>
                    <measurement group_id="O5" value="-6.23" spread="0.892"/>
                    <measurement group_id="O6" value="-4.94" spread="0.885"/>
                    <measurement group_id="O7" value="-5.70" spread="0.550"/>
                    <measurement group_id="O8" value="-4.95" spread="0.746"/>
                    <measurement group_id="O9" value="-5.38" spread="0.660"/>
                    <measurement group_id="O10" value="-4.92" spread="0.803"/>
                    <measurement group_id="O11" value="-5.01" spread="0.962"/>
                    <measurement group_id="O12" value="-5.74" spread="0.203"/>
                    <measurement group_id="O13" value="-4.80" spread="0.851"/>
                    <measurement group_id="O14" value="-5.84" spread="0.383"/>
                    <measurement group_id="O15" value="-5.19" spread="0.536"/>
                    <measurement group_id="O16" value="-5.36" spread="0.575"/>
                    <measurement group_id="O17" value="-5.18" spread="0.781"/>
                    <measurement group_id="O18" value="-4.93" spread="0.942"/>
                    <measurement group_id="O19" value="-5.35" spread="0.510"/>
                    <measurement group_id="O20" value="-5.39" spread="0.559"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HCV RNA at Week 8</title>
        <description>Data are not presented for Group 21 which ended treatment after Week 6.</description>
        <time_frame>Baseline to Week 8</time_frame>
        <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HCV RNA at Week 8</title>
          <description>Data are not presented for Group 21 which ended treatment after Week 6.</description>
          <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
          <units>log10 IU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.52" spread="0.418"/>
                    <measurement group_id="O2" value="-5.44" spread="0.519"/>
                    <measurement group_id="O3" value="-5.23" spread="0.571"/>
                    <measurement group_id="O4" value="-5.20" spread="0.756"/>
                    <measurement group_id="O5" value="-4.59" spread="0.892"/>
                    <measurement group_id="O6" value="-4.94" spread="0.885"/>
                    <measurement group_id="O7" value="-5.70" spread="0.550"/>
                    <measurement group_id="O8" value="-4.95" spread="0.746"/>
                    <measurement group_id="O9" value="-5.38" spread="0.660"/>
                    <measurement group_id="O10" value="-4.92" spread="0.803"/>
                    <measurement group_id="O11" value="-5.01" spread="0.962"/>
                    <measurement group_id="O12" value="-5.74" spread="0.203"/>
                    <measurement group_id="O13" value="-4.80" spread="0.851"/>
                    <measurement group_id="O14" value="-5.84" spread="0.383"/>
                    <measurement group_id="O15" value="-5.19" spread="0.536"/>
                    <measurement group_id="O16" value="-5.36" spread="0.575"/>
                    <measurement group_id="O17" value="-5.18" spread="0.781"/>
                    <measurement group_id="O18" value="-4.93" spread="0.942"/>
                    <measurement group_id="O19" value="-5.35" spread="0.510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HCV RNA at Week 12</title>
        <description>Data are not presented for Groups 6, 10, and 21 which ended treatment after Week 8 or Week 6. Data are not presented for Groups 16, 17, 18, and 20 because participants with detectable HCV RNA discontinued due to protocol-specified stopping rules.</description>
        <time_frame>Baseline to Week 12</time_frame>
        <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O7">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O8">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O11">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HCV RNA at Week 12</title>
          <description>Data are not presented for Groups 6, 10, and 21 which ended treatment after Week 8 or Week 6. Data are not presented for Groups 16, 17, 18, and 20 because participants with detectable HCV RNA discontinued due to protocol-specified stopping rules.</description>
          <population>Participants in the Safety Analysis Set with available data were analyzed.</population>
          <units>log10 IU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="25"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="10"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="24"/>
                <count group_id="O12" value="10"/>
                <count group_id="O13" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.52" spread="0.418"/>
                    <measurement group_id="O2" value="-5.44" spread="0.519"/>
                    <measurement group_id="O3" value="-5.23" spread="0.571"/>
                    <measurement group_id="O4" value="-5.20" spread="0.756"/>
                    <measurement group_id="O5" value="-4.59" spread="0.892"/>
                    <measurement group_id="O6" value="-5.70" spread="0.550"/>
                    <measurement group_id="O7" value="-4.95" spread="0.746"/>
                    <measurement group_id="O8" value="-5.39" spread="0.660"/>
                    <measurement group_id="O9" value="-2.01" spread="0.962"/>
                    <measurement group_id="O10" value="-5.74" spread="0.203"/>
                    <measurement group_id="O11" value="-4.85" spread="0.823"/>
                    <measurement group_id="O12" value="-5.84" spread="0.383"/>
                    <measurement group_id="O13" value="-5.19" spread="0.536"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Virologic Failure</title>
        <description>The percentage of participants with on-treatment virologic failure (viral breakthrough, rebound, or nonresponse) or following treatment (viral relapse) was summarized.
On-treatment virologic failure was defined as:
Viral breakthrough (confirmed HCV RNA ≥ LOD after having previously had HCV RNA &lt; LOD while on treatment),
Viral rebound (confirmed &gt; 1 log10 IU/mL increase in HCV RNA from nadir while on treatment, or
Nonresponse (HCV RNA persistently ≥ LOD through 6 weeks of treatment)
Viral relapse was defined as confirmed HCV RNA ≥ LOD during the posttreatment period having achieved HCV RNA &lt; LOD at the last on-treatment visit.</description>
        <time_frame>Up to Posttreatment Week 24</time_frame>
        <population>Safety Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
          </group>
          <group group_id="O2">
            <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O3">
            <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O4">
            <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O5">
            <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O6">
            <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O7">
            <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O8">
            <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O9">
            <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O10">
            <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O11">
            <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
            <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O12">
            <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O13">
            <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O14">
            <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
          </group>
          <group group_id="O15">
            <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
            <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O16">
            <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O17">
            <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
          </group>
          <group group_id="O18">
            <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
          </group>
          <group group_id="O19">
            <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
          </group>
          <group group_id="O20">
            <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
            <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Virologic Failure</title>
          <description>The percentage of participants with on-treatment virologic failure (viral breakthrough, rebound, or nonresponse) or following treatment (viral relapse) was summarized.
On-treatment virologic failure was defined as:
Viral breakthrough (confirmed HCV RNA ≥ LOD after having previously had HCV RNA &lt; LOD while on treatment),
Viral rebound (confirmed &gt; 1 log10 IU/mL increase in HCV RNA from nadir while on treatment, or
Nonresponse (HCV RNA persistently ≥ LOD through 6 weeks of treatment)
Viral relapse was defined as confirmed HCV RNA ≥ LOD during the posttreatment period having achieved HCV RNA &lt; LOD at the last on-treatment visit.</description>
          <population>Safety Analysis Set</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="25"/>
                <count group_id="O9" value="25"/>
                <count group_id="O10" value="25"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="25"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="9"/>
                <count group_id="O18" value="10"/>
                <count group_id="O19" value="14"/>
                <count group_id="O20" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>On-treatment virologic failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                    <measurement group_id="O5" value="0.0"/>
                    <measurement group_id="O6" value="0.0"/>
                    <measurement group_id="O7" value="0.0"/>
                    <measurement group_id="O8" value="0.0"/>
                    <measurement group_id="O9" value="0.0"/>
                    <measurement group_id="O10" value="0.0"/>
                    <measurement group_id="O11" value="0.0"/>
                    <measurement group_id="O12" value="0.0"/>
                    <measurement group_id="O13" value="0.0"/>
                    <measurement group_id="O14" value="0.0"/>
                    <measurement group_id="O15" value="0.0"/>
                    <measurement group_id="O16" value="0.0"/>
                    <measurement group_id="O17" value="0.0"/>
                    <measurement group_id="O18" value="0.0"/>
                    <measurement group_id="O19" value="0.0"/>
                    <measurement group_id="O20" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Viral relapse</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                    <measurement group_id="O5" value="40.0"/>
                    <measurement group_id="O6" value="0.0"/>
                    <measurement group_id="O7" value="90.0"/>
                    <measurement group_id="O8" value="16.0"/>
                    <measurement group_id="O9" value="32.0"/>
                    <measurement group_id="O10" value="36.0"/>
                    <measurement group_id="O11" value="40.0"/>
                    <measurement group_id="O12" value="0.0"/>
                    <measurement group_id="O13" value="0.0"/>
                    <measurement group_id="O14" value="0.0"/>
                    <measurement group_id="O15" value="8.0"/>
                    <measurement group_id="O16" value="30.0"/>
                    <measurement group_id="O17" value="0.0"/>
                    <measurement group_id="O18" value="20.0"/>
                    <measurement group_id="O19" value="0.0"/>
                    <measurement group_id="O20" value="32.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 12 weeks plus 30 days.</time_frame>
      <desc>Adverse events are included up to the last dose date of any study drug + 30 days.</desc>
      <group_list>
        <group group_id="E1">
          <title>Group 1: SOF+RBV 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive (TN) participants with genotype (GT) 2 or 3 HCV infection</description>
        </group>
        <group group_id="E2">
          <title>Group 2: SOF+RBV 12 wk +PEG 4 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 4 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E3">
          <title>Group 3: SOF+RBV 12 wk+PEG 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E4">
          <title>Group 4: SOF+RBV+PEG 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E5">
          <title>Group 5: SOF 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E6">
          <title>Group 6: SOF+RBV+PEG 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus PEG 180 µg once weekly for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E7">
          <title>Group 7: SOF+RBV 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced (TE) participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="E8">
          <title>Group 8: SOF+RBV 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="E9">
          <title>Group 9: SOF+RBV 12 wk: GT 2 or 3, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E10">
          <title>Group 10: SOF+RBV 8 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 8 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E11">
          <title>Group 11: SOF+RBV 12 wk: GT 2 or 3, TN</title>
          <description>SOF 400 mg once daily plus split-dose RBV (800 mg in a divided daily dose) for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E12">
          <title>Group 12: SOF+RBV+LDV 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="E13">
          <title>Group 13: SOF+RBV+LDV 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus LDV 90 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="E14">
          <title>Group 14: SOF+RBV+GS-9669 12 wk: GT 1, TE</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection who did not respond to prior treatment</description>
        </group>
        <group group_id="E15">
          <title>Group 15: SOF+RBV+GS-9669 12 wk: GT 1, TN</title>
          <description>SOF 400 mg once daily plus weight-based RBV (1000-1200 in a divided daily dose) plus GS-9669 500 mg once daily for 12 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="E16">
          <title>Group 16: LDV/SOF FDC 12 wk: GT 1, Fibrosis</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
        </group>
        <group group_id="E17">
          <title>Group 17: LDV/SOF FDC+RBV 12 wk: GT 1, Fibrosis</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in treatment-experienced participants with genotype 1 HCV infection with Stage F4 fibrosis who did not respond to prior treatment</description>
        </group>
        <group group_id="E18">
          <title>Group 18: LDV/SOF FDC 12 wk: GT 2 or 3, TN</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily for 12 weeks in treatment-naive participants with genotype 2 or 3 HCV infection</description>
        </group>
        <group group_id="E19">
          <title>Group 20: LDV/SOF FDC+RBV 12 wk: GT 1, Hemophiliac</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 12 weeks in hemophiliac participants with genotype 1 HCV infection</description>
        </group>
        <group group_id="E20">
          <title>Group 21: LDV/SOF FDC+RBV 6 wk: GT 1, TN</title>
          <description>LDV 90 mg/SOF 400 mg FDC once daily plus weight-based RBV (1000-1200 in a divided daily dose) for 6 weeks in treatment-naive participants with genotype 1 HCV infection</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (16.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diverticulitis Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Emterovesical Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Breast Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Urethral injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (16.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="25" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="24" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="25" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="24" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="25" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="8" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="13" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="22" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Eustachian tube obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Eye inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Ocular discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Anal pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Change of bowel habit</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Chapped lips</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Frequent bowel movements</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Gingival disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Gingival ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Glossodynia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="11" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="5" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Paraesthesia oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Stomatitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Application site inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Axillary pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Crying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="12" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="10" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="7" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Feeling of body temperature change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Injection site discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Injection site inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vessel puncture site bruise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vessel puncture site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Conjunctivitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vulvovaginitis trichomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Animal scratch</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Peroneal nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vessel puncture site bruise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal loss of weight</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Food craving</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Increased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Muscle atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Muscle tightness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Muscle twitching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Upper extremity mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Head discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="11" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="8" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="5" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="8" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hypogeusia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal dreams</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Affect lability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Depressive symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dysphoria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dysthymic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Impatience</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="6" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Libido decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Loss of libido</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Mood swings</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Chromaturia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Micturition urgency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Urine odour abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Amenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Menstruation delayed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Increased upper airway secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pharyngeal erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Upper-airway cough syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Catheter site bruise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Cold sweat</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Macule</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Onychoclasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin discolouration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin fissures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:
The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or
The study has been completed at all study sites for at least 2 years</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trial Disclosures</name_or_title>
      <organization>Gilead Sciences, Inc.</organization>
      <email>ClinicalTrialDisclosures@gilead.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

